Leukemia & Lymphoma Society’s Scenic Shore 150 Bike Tour Rolls Out July 21-22, 2012
2012 Bike Tour celebrates 20th anniversary as major fundraiser by shattering records
The Wisconsin Chapter of The Leukemia & Lymphoma Society’s Scenic Shore 150 Bike Tour is a two-day, 150 mile cycling event from Mequon to Sturgeon Bay with an overnight in Manitowoc. Riders travel 75 miles each day with an optional 25-mile loop on day one. Scenic Shore 150 is one of Wisconsin’s most popular bike rides and the largest locally organized and supported event for The Leukemia & Lymphoma Society.
Over 1,100 people are registered for the ride, which breaks the previous record of 964 riders. One rider, Tom Gaertner, has participated in the bike tours for all of the 20 years. Eighty-four year old Rodger Nelson has participated in 19 of the 20 rides.
Ann Marie Frakes, Executive Director of the Wisconsin Chapter of LLS, said, "2012 marks the 20th Anniversary of the Scenic Shore 150 Bike Tour. Over the years we have met many goals and have raised millions of dollars to support the LLS mission. This year, in honor of our 20th anniversary ride, we will strive to raise one million dollars."
The ride takes cyclers through some of the most scenic roads in the state; riders cycle along Lake Michigan’s shoreline and enjoy a volunteer supported route with rest stops, bicycle support, and other amenities.
Over seventy-five percent of Scenic Shore 150 donations directly support LLS and its funding for blood cancer research. Since the first funding in 1954, LLS has invested more than $750 million in blood Cancer research. In the last 49 years, LLS funded research has helped quadruple the survival rate for leukemia patients.
For more information about The Scenic Shore 150, contact Jennifer Grandkoski at
The Leukemia & Lymphoma Society®, headquartered in White Plains, NY, is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. LLS has a local Patient Services Manager in 68 chapters throughout the United States and Canada. For additional information, please contact LLS at (800) 955-4572 or visit